Rühle Alexander, Haehl Erik, David Hélène, Kalckreuth Tobias, Sprave Tanja, Stoian Raluca, Zamboglou Constantinos, Gkika Eleni, Knopf Andreas, Grosu Anca-Ligia, Nicolay Nils Henrik
Department of Radiation Oncology, University of Freiburg-Medical Center, Robert-Koch-Str. 3, 79106 Freiburg, Germany.
German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Neuenheimer Feld 280, 69120 Heidelberg, Germany.
Cancers (Basel). 2020 Jun 26;12(6):1698. doi: 10.3390/cancers12061698.
The purpose of this study was to evaluate the value of routine blood markers regarding their predictive potential for treatment outcomes of elderly head-and-neck squamous cell carcinoma (HNSCC) patients. In total, 246 elderly HNSCC patients (≥65 years) undergoing (chemo)radiotherapy from 2010 to 2018 were analyzed for treatment outcomes, depending on their hemoglobin, glomerular filtration rate (GFR), C-reactive protein (CRP) and albumin values, representing anemia, kidney function, inflammation and nutrition status, respectively. Local/locoregional control, progression-free and overall survival (OS) were calculated using the Kaplan-Meier method. Cox analyses were performed to examine the influence of blood parameters on oncological outcomes. In the univariate Cox regression analysis, hemoglobin ≤ 12 g/dL (HR = 1.536, < 0.05), a GFR ≤ 60 mL/min/1.73 m (HR = 1.537, < 0.05), a CRP concentration > 5 mg/L (HR = 1.991, < 0.001) and albumin levels ≤ 4.2 g/dL (HR = 2.916, < 0.001) were significant risk factors for OS. In the multivariate analysis including clinical risk factors, only performance status (HR = 2.460, < 0.05) and baseline albumin (HR = 2.305, < 0.05) remained significant prognosticators. Additionally, baseline anemia correlated with the prevalence of higher-grade chronic toxicities. We could show for the first time that laboratory parameters for anemia (and at least partly, tumor oxygenation), decreased renal function, inflammation and reduced nutrition status are associated with impaired survival in elderly HNSCC patients undergoing (chemo)radiotherapy.
本研究的目的是评估常规血液标志物对老年头颈部鳞状细胞癌(HNSCC)患者治疗结果的预测潜力。总共分析了2010年至2018年期间接受(化疗)放疗的246例老年HNSCC患者(≥65岁)的治疗结果,这些结果取决于他们的血红蛋白、肾小球滤过率(GFR)、C反应蛋白(CRP)和白蛋白值,分别代表贫血、肾功能、炎症和营养状况。使用Kaplan-Meier方法计算局部/区域控制、无进展生存期和总生存期(OS)。进行Cox分析以检查血液参数对肿瘤学结果的影响。在单变量Cox回归分析中,血红蛋白≤12 g/dL(HR = 1.536,<0.05)、GFR≤60 mL/min/1.73 m²(HR = 1.537,<0.05)、CRP浓度>5 mg/L(HR = 1.991,<0.001)和白蛋白水平≤4.2 g/dL(HR = 2.916,<0.001)是OS的显著危险因素。在包括临床危险因素的多变量分析中,只有体能状态(HR = 2.460,<0.05)和基线白蛋白(HR = 2.305,<0.05)仍然是显著的预后因素。此外,基线贫血与更高级别慢性毒性的发生率相关。我们首次表明,贫血(以及至少部分肿瘤氧合)、肾功能下降、炎症和营养状况降低的实验室参数与接受(化疗)放疗的老年HNSCC患者的生存受损有关。